hrp0089p2-p011 | Adrenals and HPA Axis P2 | ESPE2018

Neonatal Screening for Congenital Adrenal Hyperplasia in Turkey: A Pilot Study with 38 935 Infants

Guran Tulay , Tezel Basak , Gurbuz Fatih , Eklioglu Beray Selver , Hatipoglu Nihal , Kara Cengiz , Sahin Nuran , Simsek Enver , Cizmecioglu Filiz Mine , Ozon Alev , Bas Firdevs , Aydin Murat , Ozdemir Gulsum , Darendeliler Feyza

Background: Congenital adrenal hyperplasia (CAH) is the most common form of primary adrenal insufficiency in children. 21-hydroxylase enzyme deficiency (21-OHD) occurs in 90–95% of all cases of CAH. Despite it being a treatable condition, if unrecognized, CAH may present with life-threatening cardiovascular collapse. Mortality in the first years is reported to be higher than in the general population. Neonatal screening for CAH is effective in detecting the salt-wasting f...